Jeremy Paull

Company: Starpharma

Job title: Vice President, Development and Regulatory Affairs

Seminars:

Branching Out: DEP® Dendrimer Nanoparticles as a Versatile Platform for Precision Cancer Radiotheranostics 1:45 pm

• Starpharma’s polylysine DEP® dendrimers for development of radiotheranostic pairs • Utility of DEP® platform for targeted delivery of radiotheranostics • Overview of DEP® HER2-targeted radiotheranosticsRead more

day: Day 1 - Track A (PM)